The p53 tumor suppressor gene is one of the most frequently mutated genes in human breast cancer and includes gain of function mutations as well as deletion mutations. Until now, it has been difficult to examine the role of p53 gene deletion in experimental mammary tumorigenesis because of the early death rate of p53 null mice due to lymphosarcomas. We have developed a p53 null mammary epithelial model by backcrossing the original p53 null mouse into Balb/c mice. Transplantation of p53 null mammary epithelial cells into the mammary fat pads of syngeneic Balb/c mice provides a unique model system to examine the effects of p53 gene deletion on a single tissue: mammary epithelial cell morphogenesis and tumorigenesis. Preliminary data demonstrate that the p53 null mammary epithelial cells are highly susceptible to tumor development and the tumors are frequently aneuploid and metastatic. In this grant application, three specific aims are proposed to examine the role of p53 gene deletion on mammary tumorigenesis.
Specific aim 1 will examine the biology of the p53-null mammary epithelial cell by determining the preneoplastic pathology, hormone interactions and hormone dependency for tumorigenesis, and the timing of aneuploidy in tumorigenesis.
Specific aim 2 will examine modified gene expression due to p53 gene deletion using cDNA arrays. Gene expression will be evaluated in nontransformed (normal) and tumor cells from both p53 wild type and null cell populations.
Specific aim 3 will analyze the functional properties of genes identified in specific aim 2 using a variety of approaches that include modulating gene expression and restoration of wild type p53 gene activity in null cells. The initial gene to be analyzed will be glutathione peroxidase which was identified as downregulated in p53 null mammary cells by cDNA array analysis. In summary, this model allows one to analyze the biological, genetic and molecular consequences of p53 gene deletion in the in situ mammary gland by taking advantage of transplantation methods.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Chemical Pathology Study Section (CPA)
Program Officer
Okano, Paul
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Baylor College of Medicine
Anatomy/Cell Biology
Schools of Medicine
United States
Zip Code
Medina, Daniel; Kittrell, Frances S; Hill, Jamal et al. (2005) Tamoxifen inhibition of estrogen receptor-alpha-negative mouse mammary tumorigenesis. Cancer Res 65:3493-6
Pati, Debananda; Haddad, Bassem R; Haegele, Albert et al. (2004) Hormone-induced chromosomal instability in p53-null mammary epithelium. Cancer Res 64:5608-16
Medina, Daniel; Kittrell, Frances S; Shepard, Anne et al. (2003) Hormone dependence in premalignant mammary progression. Cancer Res 63:1067-72
Medina, Daniel (2002) Biological and molecular characteristics of the premalignant mouse mammary gland. Biochim Biophys Acta 1603:1-9
Medina, Daniel; Ullrich, Robert; Meyn, Raymond et al. (2002) Environmental carcinogens and p53 tumor-suppressor gene interactions in a transgenic mouse model for mammary carcinogenesis. Environ Mol Mutagen 39:178-83